tiprankstipranks
Trending News
More News >
Astria Therapeutics (ATXS)
NASDAQ:ATXS
US Market

Astria Therapeutics (ATXS) Cash flow

Compare
1,168 Followers

Astria Therapeutics Cash Flow

ATXS's free cash flow for Q3 2025 was $-32.30M. For the 2025 fiscal year, ATXS's free cash flow was decreased by $-13.07M and operating cash flow was $-32.30M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -81.21M$ -68.44M$ -43.53M$ -30.15M$ -32.48M
Investing Cash Flow
$ -191.86M$ 135.05M$ -167.13M$ -12.55M$ 6.30M
Financing Cash Flow
$ 157.20M$ 88.40M$ 144.72M$ 104.28M$ 40.86M
End Cash Position
$ 59.82M$ 175.69M$ 20.69M$ 86.63M$ 25.05M
Free Cash Flow
$ -81.54M$ -68.47M$ -43.62M$ -30.17M$ -32.52M
Currency in USD

Astria Therapeutics Cash Flow